Osteopathic Procedure on Pain in Palliative Care
OSTEOPAL
Evaluation of an Osteopathic Procedure in the Management of Pain in Palliative Care Patients in a Mobile Palliative Care Support Team (EMASP): Controlled, Randomized, Single-blind Study
2 other identifiers
interventional
80
1 country
1
Brief Summary
The culture of the palliative is anchored more and more in France. In 2009, nearly 9 out of 10 French people (89%) believe that palliative care can reduce the suffering of people at the end of their lives. Despite the rise of palliative care in France, their access is not homogeneous between regions. In 2010, it is estimated that 2 French out of 3 likely to receive palliative care could not access it. Palliative care remains essential at the end of the patient's life, as well as for the family and caregivers. The French government has put in place three national palliative care development programs: 2002-2005, 2008-2012, 2015-2018. The last program has unlocked a budget of 190 million euros for their development. It has been estimated from Social Security reimbursements, that the costs per patient over their last years of life are 26,000 euros, for a total of 13.5 million euros. One of the most important aspects of palliative care is the comfort of the patients as well as their feelings in the care. In order to best meet the expectations of cancer patients, some offer early palliative care that is effective in improving both the quality of life of the patient and its life expectancy. Osteopathy is a manual alternative medicine whose goal is to restore the lack of mobility of tissues. It can be used as a complementary treatment when a specific support is put in place. The purpose of this study is to examine the effectiveness of osteopathy in the reduction of pain in adult patients in palliative care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable pain
Started Mar 2019
Typical duration for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedFirst Submitted
Initial submission to the registry
May 3, 2019
CompletedFirst Posted
Study publicly available on registry
May 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedJune 23, 2021
June 1, 2021
2.2 years
May 3, 2019
June 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VAS (Visual Analog Scale) evaluation (0 to 100)
Evolution of the score of the Visual Analogue Scale (VAAS) on 100 between D0 and D6 and D0 and D1, D0 and D2, D0 and D3, D0 and D4, D0 and D5
day 6
Secondary Outcomes (2)
Dose of analgesic (g)
day 6
QLQ (Quality of life questionnaire) C15 Pal score
days 6
Study Arms (2)
Osteopathy
EXPERIMENTALManagement will be centered on the skull, the sacrum, the cranio-sacral axis, the entire visceral abdominal and thoracic system.
Simulate
PLACEBO COMPARATORThe simulated treatment will be characterized by placing the practitioner's hands on the patient in the areas tested without any intention of treatment.
Interventions
EVA questionnaire every day for 7 days. treatment (real or simulated) at J3 and J5
Eligibility Criteria
You may qualify if:
- Major patient (age\> 18) male or female
- Patient hospitalized or admitted to a day hospital that can be followed
- EVA between 40/100 and 60/100
- Signed informed consent
You may not qualify if:
- Patients requiring a modification of analgesic molecule during the study.
- Clinical stability of the patient estimated during the duration of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHI Creteil
Créteil, 94000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2019
First Posted
May 6, 2019
Study Start
March 1, 2019
Primary Completion
May 1, 2021
Study Completion
May 1, 2021
Last Updated
June 23, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share